Terms: = Brain cancer AND KIT, C-Kit, 3815, ENSG00000157404, CD117, SCFR, P10721 AND Prognosis
122 results:
1. Autophagy-related CMTM6 promotes glioblastoma progression by activating Wnt/β-catenin pathway and acts as an onco-immunological biomarker.
Dai L; Xiao J; Li X; Tao Y; Zhou P; Lyu L; Shi Z; Liang X; Jia Z; Jiang S
J Gene Med; 2024 May; 26(5):e3685. PubMed ID: 38686653
[TBL] [Abstract] [Full Text] [Related]
2. Regorafenib and glioblastoma: a literature review of preclinical studies, molecular mechanisms and clinical effectiveness.
Mongiardi MP; Pallini R; D'Alessandris QG; Levi A; Falchetti ML
Expert Rev Mol Med; 2024 Apr; 26():e5. PubMed ID: 38563164
[TBL] [Abstract] [Full Text] [Related]
3. Comprehensive genomic profiling to identify actionable alterations for breast cancer brain metastases in the Chinese population.
Lu Q; Wang N; Jiang K; Zhou H; Zhang P; Zhang J; Wang S; Sun P; Xu F
ESMO Open; 2024 Mar; 9(3):102389. PubMed ID: 38460250
[TBL] [Abstract] [Full Text] [Related]
4. CNS erythroblastic sarcoma: a potential emerging pediatric tumor type characterized by NFIA::RUNX1T1/3 fusions.
Tauziède-Espariat A; Lew-Derivry L; Abbou S; Métais A; Pierron G; Reynaud S; Masliah-Planchon J; Mariet C; Hasty L; Dangouloff-Ros V; Boddaert N; Csanyi M; Aline-Fardin A; Lamaison C; Chrétien F; Beccaria K; Puget S; Varlet P
Acta Neuropathol Commun; 2024 Jan; 12(1):12. PubMed ID: 38243303
[TBL] [Abstract] [Full Text] [Related]
5. Avapritinib-based SAR studies unveil a binding pocket in kit and PDGFRA.
Teuber A; Schulz T; Fletcher BS; Gontla R; Mühlenberg T; Zischinsky ML; Niggenaber J; Weisner J; Kleinbölting SB; Lategahn J; Sievers S; Müller MP; Bauer S; Rauh D
Nat Commun; 2024 Jan; 15(1):63. PubMed ID: 38167404
[TBL] [Abstract] [Full Text] [Related]
6. Overexpression of TMEM150A in glioblastoma multiforme patients correlated with dismal prognoses and compromised immune statuses.
Fan ST; Xu HQ; He Y; Tu MX; Shi K; Zhang YQ; Guo Q; Yang WQ; Qin Y
PLoS One; 2023; 18(12):e0294144. PubMed ID: 38055673
[TBL] [Abstract] [Full Text] [Related]
7. Total DNA methylation profile in assessing the MGMT gene promoter status in malignant gliomas.
Petrova EI; Galstyan SA; Telysheva EN; Ryzhova MV
Zh Vopr Neirokhir Im N N Burdenko; 2023; 87(6):52-58. PubMed ID: 38054227
[TBL] [Abstract] [Full Text] [Related]
8. Advances in genetic abnormalities, epigenetic reprogramming, and immune landscape of intracranial germ cell tumors.
Zhang Y; Zhong C; Ke X; Liu J; Ye Z; Lu L; Deng K; Zhu H; Yao Y
Acta Neuropathol Commun; 2023 Nov; 11(1):188. PubMed ID: 38012690
[TBL] [Abstract] [Full Text] [Related]
9. Warburg effect-related risk scoring model to assess clinical significance and immunity characteristics of glioblastoma.
Zhang R; Wang C; Zheng X; Li S; Zhang W; Kang Z; Yin S; Chen J; Chen F; Li W
Cancer Med; 2023 Nov; 12(21):20639-20654. PubMed ID: 37864422
[TBL] [Abstract] [Full Text] [Related]
10. General features, pathogenesis, and laboratory diagnostics of autoimmune encephalitis.
Masciocchi S; Businaro P; Scaranzin S; Morandi C; Franciotta D; Gastaldi M
Crit Rev Clin Lab Sci; 2024 Jan; 61(1):45-69. PubMed ID: 37777038
[TBL] [Abstract] [Full Text] [Related]
11. Cuproptosis-related gene SLC31A1 expression correlates with the prognosis and tumor immune microenvironment in glioma.
Wang J; Li S; Guo Y; Zhao C; Chen Y; Ning W; Yang J; Zhang H
Funct Integr Genomics; 2023 Aug; 23(3):279. PubMed ID: 37610668
[TBL] [Abstract] [Full Text] [Related]
12. A prognostic biomarker NRG1 promotes U-87 MG glioblastoma cell malignancy by inhibiting autophagy via ERBB2/AKT/mTOR pathway.
Lin JZ; Lin N; Zhao WJ
J Cell Biochem; 2023 Sep; 124(9):1273-1288. PubMed ID: 37450666
[TBL] [Abstract] [Full Text] [Related]
13. The RNA polymerase II subunit B (RPB2) functions as a growth regulator in human glioblastoma.
Li XL; Xie Y; Chen YL; Zhang ZM; Tao YF; Li G; Wu D; Wang HR; Zhuo R; Pan JJ; Yu JJ; Jia SQ; Zhang Z; Feng CX; Wang JW; Fang F; Qian GH; Lu J; Hu SY; Li ZH; Pan J
Biochem Biophys Res Commun; 2023 Sep; 674():170-182. PubMed ID: 37423037
[TBL] [Abstract] [Full Text] [Related]
14. Inhibition of extranodal NK/T-cell lymphoma by Chiauranib through an AIF-dependent pathway and its synergy with L-asparaginase.
Gao T; Huang J; Yin H; Huang J; Xie J; Zhou T; Fan W; Yang X; Gao G; Li Z
Cell Death Dis; 2023 May; 14(5):316. PubMed ID: 37160920
[TBL] [Abstract] [Full Text] [Related]
15. Platycodin D suppresses proliferation, migration, and invasion of human glioblastoma cells through regulation of Skp2.
Li H; Ouyang J; Liu R
Eur J Pharmacol; 2023 Jun; 948():175697. PubMed ID: 36997048
[TBL] [Abstract] [Full Text] [Related]
16. Deciphering the molecular mechanism of the THBS1 gene in the TNF signaling axis in glioma stem cells.
Chen L; Fang W; Chen W; Wei Y; Ding J; Li J; Lin J; Wu Q
Cell Signal; 2023 Jun; 106():110656. PubMed ID: 36935087
[TBL] [Abstract] [Full Text] [Related]
17. Genetic testing in the evaluation of individuals with clinical diagnosis of atypical Sturge-Weber syndrome.
Yeom S; Cohen B; Weiss CR; Montano C; Wohler E; Sobreira N; Hammill AM; Comi A
Am J Med Genet A; 2023 Apr; 191(4):983-994. PubMed ID: 36710374
[TBL] [Abstract] [Full Text] [Related]
18. CircZNF236 facilitates malignant progression in oral squamous cell carcinoma by sequestering miR-145-5p.
Lu Q; Che H; Che Y; Hu M
Clin Transl Oncol; 2023 Jun; 25(6):1690-1701. PubMed ID: 36635458
[TBL] [Abstract] [Full Text] [Related]
19. ceRNA network of lncRNA MIR210HG/miR-377-3p/LMX1A in malignant proliferation of glioma cells.
Yu Z; Che N; He Y; Zhang B
Genes Genomics; 2022 Dec; 44(12):1445-1455. PubMed ID: 36197580
[TBL] [Abstract] [Full Text] [Related]
20. Dynamics of cell-free DNA in predicting response in adult diffuse glioma on chemoradiotherapy.
Husain A; Mishra S; Hadi R; Sahu A; Kumari S; Rastogi M; Khurana R; Shukla S; Siddiqui MH; Husain N
Cancer Genet; 2022 Nov; 268-269():55-63. PubMed ID: 36166960
[TBL] [Abstract] [Full Text] [Related]
[Next]
